Drug Discovery Series Virtual

Attracting leading experts & the brightest minds in the industry to educate, inform and excite our attendees.

The following are confirmed speakers for the 2020 Series.

Andrea Zuhl

Senior Scientist, Discovery Sciences, BioPharmaceuticals R&D

AstraZeneca

Andrew Zhang

Team Leader Chemical Biology

AstraZeneca

Brandon Allgood

Chief Technology Officer

Integral Health

Brinton Seashore-Ludlow

Assistant Professor

Karolinska Institute and SciLifeLab

Chris De Graaf

Director, Head of Computational Chemistry

Sosei Heptares

Christiane Volbracht

Principal Scientist Neurobiologist

H. Lundbeck A/S

David Evans

Chief Scientific Officer

Sirnaomics

Davide Danovi

Director, HipSci Cell Phenotyping Centre for Stem Cells & Regenerative Medicine

King's College London

Davide Gianni

Associate Director

AstraZeneca

Dimitrios Tzalis

Founder and Chief Executive Officer

Taros Chemicals GmbH & Co. KG

Emmanuel Gustin

Principal Scientist

Janssen Pharmaceuticals

Felix Gnerlich

Principal Scientist

AstraZeneca

Fiona Pachl

Senior Scientist, Discovery Sciences, BioPharmaceuticals R&D

AstraZeneca

Frank Mercurio

Chief Scientific Officer

BioTheryX, Inc.

Franky Van Herreweghe

Business Development Manager

Confo Therapeutics

Gregory Vladimer

Chief Scientific Officer

Allcyte GmbH

Hansjürgen Volkmer

Professor

University of Tübingen

Hasane Ratni

Expert Scientist

F. Hoffmann-La Roche Ltd

Ingrid Wertz

Senior Scientist Discovery Oncology and Early Discovery Biochemistry

Genentech

Iolanda Micco

Associate Director of Chemistry and Alliances

Vipergen

John Delaney

Executive Director, Research

Amgen

John Karanicolas

Professor

Fox Chase Cancer Centre

Jonathan Mason

Senior Research Fellow

Heptares Therapeutics

Juan F. Espinosa

Senior Research Advisor and Group Leader, Discovery Chemistry Research and Technologies

Eli Lilly and Company

Katelyn Cassidy

Senior Scientist, Chemical Biology, Discovery Sciences, BioPharmaceuticals R&D

AstraZeneca

Lutz Mueller

Project Leader Non-Clinical Safety

F. Hoffmann-La Roche Ltd

Markus Schade

Scientific Director

Grünenthal

Martin Akerman

Co-Founder and Chief Technology Officer

Envisagenics

Martin-Immanuel Bittner

Chief Executive Officer

Arctoris Ltd

Matthias Frech

Director

Merck

Maurizio Aiello

Chief Executive Officer

React4life

Michael Plewe

Vice President of Medicinal Chemistry

Cullgen Inc.

Milana Maletic

Director Discovery Chemistry

MSD

Morten Dahl Sørensen

Senior Manager, MedChem I

LEO Pharma

Ola Engkvist

Associate Director, MolecularAI, Discovery Sciences, R&D

AstraZeneca

Oliver Rausch

Chief Security Officer

Storm Therapeutics

Pekka Kallunki

Principal Scientist Project Leader

H. Lundbeck A/S

Quentin Perron

Co-Founder & Chief Scientific Officer

Iktos

Ravindra Peravali

Head Screening Center

Karlsruhe Institute of Technology

Rebecca Randle

Scientific Leader and Associate Fellow

GlaxoSmithKline

Richard Lewis

Global Head CADD

Novartis

Rolf Jautelat

Vice President Medicinal Chemistry

Bayer AG

Romina Vuono

Principal Investigator and Lecturer, Neuroscience

University of Kent

Silvia Scaglione

Chief Scientist

React4life

Stefan Geschwindner

Associate Director / Head of Biophysics, R&D

AstraZeneca

Stefan Gradl

Senior Scientist

Bayer AG

Stefano Piotto

Associate Professor, Department of Pharmacy

University of Salerno

Steve Rees

Vice-President, Discovery Biology

AstraZeneca

Steven Wagner

Professor, Neuroscience

University of California, San Diego

Stuart Hughes

Chief Executive Officer

Pathios Therapeutics

Sudeep Prajapati

Associate Director

H3 Biomedicine

Sylvia F Boj

Scientific Director

Hubrecht Organoid Technology

Tauseef Butt

President and Chief Executive Officer

Progenra Inc

Thomas Evangelidis

Research Scientist

IOCB - Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences and CEITEC

Thorsten Thormann

Senior Vice President New Product Discovery

Leo Pharma

Torsten Hoffmann

Senior Vice President Drug Discovery

Taros GmbH

Vid Stojevic

Co-Founder and Chief Technology Officer

GTN

Willem Van Hoorn

Chief Decision Scientist

Exscientia

William Farnaby

Team Leader, Medicinal Chemistry and Chemical Biology

University of Dundee

Wolfgang Fecke

Director General

EU-OPENSCREEN

Yang Teng

Co-Director, Neurotrauma Recovery Research, Director, Laboratory of SCI, Stem Cell & Recovery Neurobiology Research

Harvard Medical School

Yi Zhang

Associate Director

Kymera Tx

: Speakers

Speakers

Attracting leading experts & the brightest minds in the industry to educate, inform and excite our attendees.

The following are confirmed speakers for the 2020 Series.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.

Download Brochure

Full details regarding the Discovery Series: Virtual are available for download in the Conference Brochure